Drug to cure recurring malaria approved in 60 years

After 60 years, authorities in the United States have approved a pill that will treat malaria. According to a report the drug, tafenoquine is being described as a “phenomenal achievement” and will treat the recurring form of malaria, caused by the parasite plasmodium vivax, to which around 8.5 million people fall prey to every year. This form of malaria is the most common type to afflict people outside Sub-Saharan Africa and presents its own set of challenges as it remains dormant in the human body for years before reawakening many times. The infected person, therefore, become unwitting reservoirs of the germ. The drug will essentially help in purging the body of the parasite that normally hides in the liver.